CA2159070A1 - Cyclic compounds useful as inhibitors of platelet glycoprotein iib/iiia - Google Patents

Cyclic compounds useful as inhibitors of platelet glycoprotein iib/iiia

Info

Publication number
CA2159070A1
CA2159070A1 CA002159070A CA2159070A CA2159070A1 CA 2159070 A1 CA2159070 A1 CA 2159070A1 CA 002159070 A CA002159070 A CA 002159070A CA 2159070 A CA2159070 A CA 2159070A CA 2159070 A1 CA2159070 A1 CA 2159070A1
Authority
CA
Canada
Prior art keywords
alkyl
asp
substituted
compound
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002159070A
Other languages
English (en)
French (fr)
Inventor
William Frank Degrado
Sharon Anne Jackson
Shaker Ahmed Mousa
Anju Parthasarathy
Michael Sworin
Maria Rafalski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Pharma Co
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2159070A1 publication Critical patent/CA2159070A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • C07K14/75Fibrinogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002159070A 1993-03-29 1994-03-28 Cyclic compounds useful as inhibitors of platelet glycoprotein iib/iiia Abandoned CA2159070A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3844893A 1993-03-29 1993-03-29
US08/038,448 1993-03-29

Publications (1)

Publication Number Publication Date
CA2159070A1 true CA2159070A1 (en) 1994-10-13

Family

ID=21900014

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002159070A Abandoned CA2159070A1 (en) 1993-03-29 1994-03-28 Cyclic compounds useful as inhibitors of platelet glycoprotein iib/iiia

Country Status (10)

Country Link
EP (1) EP0691987A1 (no)
JP (1) JPH08508498A (no)
AU (1) AU6415894A (no)
CA (1) CA2159070A1 (no)
FI (1) FI954556A0 (no)
HU (1) HUT72896A (no)
NO (1) NO953832L (no)
NZ (1) NZ263456A (no)
PL (1) PL310896A1 (no)
WO (1) WO1994022910A1 (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08509708A (ja) * 1993-03-29 1996-10-15 ザ・デュポン・メルク・ファーマシュウティカル・カンパニー 血小板糖蛋白▲II▼b/▲III▼a抑制剤の調製のための新規な方法および中間体化合物
US5879657A (en) * 1993-03-30 1999-03-09 The Dupont Merck Pharmaceutical Company Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders
KR100512671B1 (ko) * 1996-11-27 2005-09-07 아벤티스 파마슈티칼스 인크. 항 Xa 활성을 지닌 화합물 및 혈소판 응집 길항제 화합물을포함하는 약제학적 조성물
US6010911A (en) * 1997-04-30 2000-01-04 Medtronic, Inc. Apparatus for performing a heparin-independent high sensitivity platelet function evaluation technique
US6537520B1 (en) 1998-03-31 2003-03-25 Bristol-Myers Squibb Pharma Company Pharmaceuticals for the imaging of angiogenic disorders
GB0623607D0 (en) 2006-11-27 2007-01-03 Haemostatix Ltd Tissue adhesive
CA2677045C (en) 2007-01-31 2016-10-18 Dana-Farber Cancer Institute, Inc. Stabilized p53 peptides and uses thereof
AU2008232709C1 (en) 2007-03-28 2015-01-15 President And Fellows Of Harvard College Stitched polypeptides
US11673914B2 (en) 2009-11-10 2023-06-13 Allegro Pharmaceuticals, LLC Peptide therapies for reduction of macular thickening
ES2730927T3 (es) 2009-11-10 2019-11-13 Allegro Pharmaceuticals Llc Composiciones y métodos para inhibir la adhesión celular o dirigir agentes diagnósticos o terapéuticos a sitios de unión a RGD
SI2603600T1 (sl) 2010-08-13 2019-04-30 Aileron Therapeutics, Inc. Peptidomimetični makrocikli
JP6106159B2 (ja) 2011-05-09 2017-03-29 アレグロ ファーマシューティカルズ インコーポレイテッドAllegro Pharmaceuticals,Inc. R−g−システイン酸ペプチドを含む医薬組成物
TWI643868B (zh) 2011-10-18 2018-12-11 艾利倫治療公司 擬肽巨環化合物
US8987414B2 (en) 2012-02-15 2015-03-24 Aileron Therapeutics, Inc. Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
KR102112373B1 (ko) 2012-02-15 2020-05-18 에일러론 테라퓨틱스 인코포레이티드 펩티드모방체 마크로사이클
AU2013337388B2 (en) 2012-11-01 2018-08-02 Aileron Therapeutics, Inc. Disubstituted amino acids and methods of preparation and use thereof
AU2015320545C1 (en) 2014-09-24 2020-05-14 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and formulations thereof
WO2016049359A1 (en) 2014-09-24 2016-03-31 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and uses thereof
MX2017011834A (es) 2015-03-20 2018-04-11 Aileron Therapeutics Inc Macrociclos peptidomimeticos y usos de los mismos.
JP2018528217A (ja) 2015-09-10 2018-09-27 エルロン・セラピューティクス・インコーポレイテッドAileron Therapeutics,Inc. Mcl−1のモジュレーターとしてのペプチド模倣大環状分子

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2636066B1 (fr) * 1988-09-02 1991-10-25 Centre Nat Rech Scient Derives de cyclopeptides, utilisables comme inhibiteurs selectifs vis-a-vis de proteases a serine active
US5384309A (en) * 1989-07-17 1995-01-24 Genentech, Inc. Cyclized peptides and their use as platelet aggregation inhibitors
AU6470590A (en) * 1989-10-23 1991-04-26 Smithkline Beecham Corporation Cyclic anti-aggregatory peptides
IL103252A (en) * 1991-09-30 1997-03-18 Du Pont Merck Pharma CYCLIC COMPOUNDS USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Also Published As

Publication number Publication date
JPH08508498A (ja) 1996-09-10
PL310896A1 (en) 1996-01-08
FI954556A (fi) 1995-09-26
EP0691987A1 (en) 1996-01-17
FI954556A0 (fi) 1995-09-26
HU9502832D0 (en) 1995-11-28
WO1994022910A1 (en) 1994-10-13
HUT72896A (en) 1996-06-28
AU6415894A (en) 1994-10-24
NO953832L (no) 1995-11-28
NZ263456A (en) 1996-11-26
NO953832D0 (no) 1995-09-28

Similar Documents

Publication Publication Date Title
CA2159070A1 (en) Cyclic compounds useful as inhibitors of platelet glycoprotein iib/iiia
AU672178B2 (en) Cyclic compounds useful as inhibitors of platelet glycoprotein IIb/IIIa
Koivunen et al. Phage libraries displaying cyclic peptides with different ring sizes: ligand specificities of the RGD-directed integrins
EP0692982B1 (en) RADIOLABELED PLATELET GPIIb/IIIa RECEPTOR ANTAGONISTS AS IMAGING AGENTS FOR THE DIAGNOSIS OF THROMBOEMBOLIC DISORDERS
RU2157379C2 (ru) Циклопептиды, способ их получения, содержащая их фармацевтическая композиция, способ ее получения
US5635477A (en) Cyclic compounds useful as inhibitors of platelet glycoprotein IIB/IIIA
CZ397991A3 (en) Cyclic anti-aggregation peptides
US5849693A (en) Cyclic compounds linked by a heterocyclic ring useful as inhibitors of platelet glycoprotein IIb/IIIa
US6056958A (en) Method of treatment of arterial and venous thromboembolic disorders
WO1995023811A1 (en) Novel carbocyclic compounds which inhibit platelet aggregation by interaction with the gpiib/iiia receptor complex
NZ265753A (en) Preparation of platelet glycoprotein iib/iiia inhibitors containing methylarginine
US5817749A (en) Processes and intermediate compounds for the preparation of platelet glycoprotein IIb/IIIa inhibitors
RU2096415C1 (ru) Циклические пептиды или их фармацевтически приемлемые соли, фармацевтическая композиция
AU6663794A (en) Processes and intermediate compounds useful for the preparation of platelet glycoprotein iib/iiia inhibitors

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead